By Marcus A. Banks
Integrated delivery networks (IDNs) will be critical in improving access to cell and gene therapies in the coming years, with artificial intelligence and data-mining of electronic health records (EHRs) among the tools they will use to optimize outcomes, according to panelists at Asembia’s AXS25 Summit, in Las Vegas.